Tao Jia
- Molecular Medicine top 10%
-
- Advanced biosensing and bioanalysis techniques 5
- Angiogenesis and VEGF in Cancer 4
- PI3K/AKT/mTOR signaling in cancer 3
- Fibroblast Growth Factor Research 3
-
- Lymphoma Diagnosis and Treatment 5
-
- Cardiac Valve Diseases and Treatments 4
- Cardiovascular Function and Risk Factors 3
-
- Viral-associated cancers and disorders 4
- Co-authors
- Jean‐Luc CollBéatrice EyminJun ZhangYale DuanLi ZhangMin ZhangGang WangVéronique Josserand
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Tao Jia
56 papers receiving 710 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 131
- Molecular Medicine 40
- Molecular Biology 408
- Biomaterials 60
- Immunology and Allergy 23
Countries citing papers authored by Tao Jia
This map shows the geographic impact of Tao Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Jia more than expected).
Fields of papers citing papers by Tao Jia
This network shows the impact of papers produced by Tao Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Jia. The network helps show where Tao Jia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Jia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 11 | |
| 11 | circRNA Hsa_circ_0020850 Silence Represses the Development of Lung Adenocarcinoma via Regulating miR-195-5p/IRS2 Axis | 2020 | 1 |
| 12 | 2020 | 38 | |
| 13 | 2019 | 17 | |
| 14 | 2018 | 33 | |
| 15 | 2018 | 2 | |
| 16 | 2017 | 13 | |
| 17 | 2014 | 90 | |
| 18 | 2013 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2009 | 6 |
About Tao Jia
Tao Jia is a scholar working on Immunology and Allergy, Molecular Biology and Cancer Research, having authored 60 papers that have together received 716 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Cardiac Valve Diseases and Treatments (4 papers), Viral-associated cancers and disorders (4 papers), Angiogenesis and VEGF in Cancer (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Fibroblast Growth Factor Research (3 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Cancer Research (131 citations), Molecular Medicine (40 citations) and Molecular Biology (408 citations). Tao Jia has collaborated with scholars based in China, France and United States. Frequent co-authors include Jean‐Luc Coll, Béatrice Eymin, Jun Zhang, Yale Duan, Li Zhang, Min Zhang, Gang Wang, Véronique Josserand, Florence Ruggiero and Elisabeth Vaganay.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.